BPA Call HT001423A0016-HT009025FG0910057
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bassett, CA 91746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products for premature and critically ill infants. The contract, valued at $15,817.86, is for the purchase of Prolacta's breastmilk supplementation products to be used in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The contract has a period of performance through...
- The Defense Health Agency, a component of the Department of Defense, awarded a $24,683.09 firm fixed price blanket purchase agreement call contract to Prolacta Bioscience, Inc. of Bassett, California. The contract is to provide breastmilk products to support neonatal intensive care unit patients from July 13, 2023 through September 30, 2023. As the leading government agency providing healthcare services to military service members, veterans, and their families, the Defense Health Agency utilizes...
- <p>The Defense Health Agency (DOD) awarded a $250,000 Firm Fixed Price Blanket Purchase Agreement Call contract to Prolacta Bioscience, Inc. to provide Human Milk Products. Prolacta Bioscience, Inc. will perform the work at their location in Bassett, California. The period of performance for this contract is September 30, 2023 through September 30, 2023.</p>
- This is a federal contract award to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products for premature and critically ill infants. The contract, valued at $24,533.58, is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a component of the Department of Defense. The contract is for the provision of Prolacta's donor breastmilk products to be used in Neonatal Intensive Care Units (NICUs) at military medical facilities. This is not...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for the provision of breastmilk fortification products for use in neonatal intensive care units (NICUs). The contract has a ceiling value of $24,838.83 and a performance period through September 30, 2025. No set-aside was used for this award. Prolacta Bioscience is a for-profit manufacturer that specializes in human milk-based nutritional products...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
- <p>Prolacta Bioscience, Inc. was awarded a $24,609 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to purchase breastmilk fortification products for premature infants. The contract supports the purchase of these specialized nutrition products through September 30, 2023. No set-aside provisions were applied to this award made under an existing BPA vehicle to supply critical needs for the healthcare of newborns in military treatment facilities.</p>
- This is a $96,228 firm fixed price purchase order awarded by the U.S. Army Medical Command to Prolacta Bioscience, Inc. for PROLACTA+6 H2MF 30 ML (93901-30) human milk-based nutritional products. The award has an ultimate completion date of December 31, 2018 and was made on October 11, 2018. Prolacta Bioscience is a for-profit manufacturer that specializes in human milk-based therapies for premature and critically ill infants in neonatal intensive care units. This contract is not associated with...
- This firm-fixed-price blanket purchase agreement (BPA) call was awarded by the Defense Health Agency (DHA) to Abbott Laboratories' Abbott Nutrition division for the delivery of nutritional supplements for clinical use. The contract has a ceiling value of $23,464.08 and a period of performance ending on September 30, 2017. This award was not set aside for small businesses. Abbott Laboratories is a large, for-profit manufacturer of medical devices, pharmaceuticals, and nutritional products, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,592.64 firm fixed-price delivery order is for PROLIA 60 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a wide...